A vs ABBV: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Abbvie Inc in 2026
A
Agilent Technologies Inc
$121.87
ABBV
Abbvie Inc
$208.38
Key Metrics Comparison
| Metric | A | ABBV | Winner |
|---|---|---|---|
| Market Cap | $33.45B | $369.65B | ABBV |
| P/E Ratio | 26.45 | 88.56 | A |
| EPS (TTM) | $4.47 | $2.36 | A |
| Revenue Growth | 0.1% | 0.1% | ABBV |
| Gross Margin | 52.3% | 71.6% | ABBV |
Analyze A
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or ABBV a better investment?
Comparing A and ABBV: Agilent Technologies Inc has a market cap of $33.45B while Abbvie Inc has $369.65B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and ABBV?
A (Agilent Technologies Inc) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or ABBV?
Based on P/E ratios, A trades at a lower multiple (26.5x vs 88.6x).
Which is growing faster: A or ABBV?
ABBV has higher revenue growth at 0.1% vs 0.1% for A.
Which company is more profitable: A or ABBV?
Abbvie Inc (ABBV) has higher gross margins at 71.6% compared to 52.3% for A.
Which is the larger company: A or ABBV?
Abbvie Inc (ABBV) is larger with a market cap of $369.65B compared to $33.45B for A.
Should I buy A or ABBV in 2026?
Both A and ABBV have investment merit. A trades at $121.87 while ABBV trades at $208.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and ABBV stock?
Key differences: Market Cap ($33.45B vs $369.65B), P/E Ratio (26.5x vs 88.6x), Revenue Growth (0.1% vs 0.1%), Gross Margin (52.3% vs 71.6%).